The Ministry of Health has reassured HIV/AIDS patients of continued access to antiretroviral drugs (ARVs) following the United States’ withdrawal from the World Health Organization (WHO) and the suspension of global health aid, including funding from the President’s Emergency Plan for AIDS Relief (PEPFAR).
Speaking in Mombasa, Director General for Health Dr. Patrick Amoth said that despite the challenges posed by the U.S. decision, the ministry is strengthening regional collaborations and exploring alternative health financing mechanisms.
“Kenya has made significant strides in the fight against HIV/AIDS, with 98% of people living with HIV aware of their status and on treatment, and 94% achieving viral suppression. We are actively working with development partners and investing in local pharmaceutical manufacturing to prevent disruptions in treatment,” said Dr. Amoth.
The WHO expressed concern over the U.S. decision, warning that cutting funding for HIV programs could endanger the lives of over 30 million people globally and set back progress in public health innovations. WHO has pledged to support PEPFAR, national governments, and other partners to manage the transition and minimize the impact on people living with HIV.
In other health updates, the Ministry reported a rise in Social Health Authority (SHA) registration, with over 18.5 million Kenyans now enrolled. Mombasa County has seen a significant 58% increase in just eight days, with the county now having the highest registration rate in the country at 43.5% of its population. Dr. Amoth attributed the rise to the Rapid Results Initiative (RRI), which uses schools, community health promoters, and local leaders to drive registration efforts.